Regen BioPharma, Inc.'s Immune Checkpoint Inhibitor Found to Stimulate Key Immune System Proteins Interleukin-17 and Interleukin-18
KUSI News,
SOURCE Regen BioPharma Inc. Results from Ongoing Studies Suggest Major Role of Regen's NR2F6 Target in Controlling Key Immune…